IIROC Trade Resumption - LABS

About this update from Medipharm Labs Corp.

[{"type":"text","content":"\n \n \n \n IIROC Trade Resumption - LABS\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n TORONTO\n \n ,\n \n \n Dec. 22, 2022\n \n \n /CNW/ - Trading resumes in:\n \n \n Company:\n \n MediPharm Labs Corp.\n \n \n \n TSX Symbol:\n \n LABS\n \n \n \n All Issues: Yes\n \n \n Resumption (ET):\n \n 9:30 AM\n \n \n \n IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in\n \n Canada\n \n .\n \n \n SOURCE Investment Industry Regulatory Organization of\n \n Canada\n \n (IIROC) - Halts/Resumptions\n \n \n \n \n \n \n View original content:\n \n http://www.newswire.ca/en/releases/archive/December2022/22/c3378.html\n \n \n \n \n\n","length":2378,"tagName":"div"}]

More updates from Medipharm Labs Corp.